Zepbound vs Wegovy: Which GLP-1 Medication Works Better and Is Right for You?

If you're standing at the crossroads of choosing between Zepbound and Wegovy, you're not alone. These are two of the most talked-about weight loss medications right now, and for good reason—both deliver real, meaningful results. But here's the thing: they're not identical twins. They work differently in your body, have different side effect profiles, and honestly, one might be a better fit for you than the other. Let's walk through what you actually need to know.

The Basic Difference: What Makes Them Unique

Both Zepbound and Wegovy belong to a class of medications that mimic hormones your gut naturally produces to regulate appetite and blood sugar. But here's where they split paths.

Wegovy contains semaglutide, which activates one receptor in your body—the GLP-1 receptor. Think of it as turning on one very powerful switch that tells your brain you're full, slows down how quickly food leaves your stomach, and helps regulate your blood sugar.

Zepbound contains tirzepatide, which is what we call a dual agonist. It activates both the GLP-1 receptor and another one called GIP. That second receptor adds an extra layer of metabolic support, potentially enhancing how your body processes fat and responds to insulin. It's like turning on two complementary switches instead of one.

Weight Loss Results: What the Research Actually Shows

Let's talk numbers, because that's probably what you care about most.

In clinical trials, Wegovy helped people lose an average of 15-17% of their body weight over 68 weeks. That's substantial—for someone weighing 200 pounds, that's around 30-34 pounds.

Zepbound's trials showed even more impressive results, with average weight loss of 18-22% over 72 weeks. For that same 200-pound person, we're talking 36-44 pounds. The highest dose of Zepbound (15 mg) had some participants losing up to 25% of their body weight.

But here's what those averages don't tell you: individual responses vary widely. Some people respond beautifully to Wegovy and feel it's perfect for them. Others find Zepbound's dual-action approach works better with their body chemistry. There's no crystal ball here—just educated starting points.

Side Effects: The Honest Truth

Both medications come with similar potential side effects because they work on overlapping pathways. The most common ones you might experience include nausea, occasional vomiting, diarrhea, constipation, and stomach discomfort. These typically hit hardest when you first start or increase your dose.

Here's the nuance: some patients report that Zepbound causes slightly less nausea than Wegovy, possibly because the GIP receptor activation has some protective effects on the stomach. But this isn't universal—plenty of people tolerate Wegovy beautifully and have trouble with Zepbound, or vice versa.

The key with both medications is starting low and going slow with dose increases. Your body needs time to adjust, and rushing the process usually means more side effects, not faster results.

Dosing and Administration

Both Zepbound and Wegovy are once-weekly injections that you give yourself, usually in your abdomen, thigh, or upper arm. The injection itself is straightforward—most people find it much easier than they expected.

Wegovy starts at 0.25 mg and gradually increases to a maintenance dose of 2.4 mg over about four months. Zepbound starts at 2.5 mg and can increase up to 15 mg, with the titration schedule adjusted based on how you're responding and tolerating the medication.

One practical difference: Zepbound's starting dose is actually higher in absolute terms, but because it works on two receptors, the GLP-1 effect at that dose is roughly comparable to Wegovy's starting point. It's apples and oranges in terms of direct mg-to-mg comparison.

Who Might Do Better on Wegovy

Wegovy might be the better choice if you're looking for a medication with a longer track record—semaglutide has been used for diabetes management since 2017 and for weight loss since 2021. If you're someone who feels more comfortable with established treatments, that might matter to you.

Some people also find Wegovy's side effect profile more manageable, particularly if they're sensitive to medications in general. Starting with a single-receptor approach and seeing how your body responds can make sense, especially if this is your first time trying a GLP-1 medication.

Wegovy may also be preferable if you have a history of pancreatitis or significant gastrointestinal issues, though both medications require careful consideration in these cases. Your doctor should review your complete medical history before prescribing either one.

Who Might Do Better on Zepbound

If you have both weight management goals and prediabetes or type 2 diabetes, Zepbound's dual action on both GLP-1 and GIP receptors might give you an edge with blood sugar control. The GIP component seems to enhance insulin response in a way that some people find beneficial.

For those who've tried semaglutide before (either Wegovy or its diabetes counterpart, Ozempic) and hit a plateau or didn't get the results they hoped for, switching to tirzepatide's dual-action approach sometimes breaks through that barrier.

There's also emerging data suggesting that Zepbound might have slightly more favorable effects on metabolic markers beyond just weight—things like liver fat, cholesterol panels, and inflammation markers. If you're dealing with metabolic syndrome or fatty liver disease, this could be relevant.

For Women: What You Should Know

Women's bodies respond powerfully to both medications, though you might experience more pronounced nausea, especially during the first few weeks or around your menstrual cycle when hormones fluctuate. Staying hydrated and eating small, protein-rich meals can help significantly. If you're of childbearing age, know that both medications are not recommended during pregnancy, and you should use reliable contraception while taking them. Weight loss itself can also affect fertility by changing hormone levels, so if pregnancy is in your near-term plans, discuss timing with your doctor.

For Men: What You Should Know

Men often see robust results with both medications and frequently tolerate dose increases well. If you're carrying weight primarily in your abdomen (which is common for men and comes with higher metabolic risk), both Zepbound and Wegovy can help reduce that visceral fat significantly. Some men report that the appetite suppression feels particularly helpful for controlling portion sizes and late-night eating patterns that may have been hard to break before.

Cost Considerations

Here's where things get real: both brand-name medications are expensive—often $1,000-$1,300 per month without insurance coverage. Insurance coverage varies widely, and prior authorization can be a frustrating process.

This is where compounded versions come in. Compounded semaglutide and tirzepatide, available through telehealth providers like Ozari, offer the same active ingredients at a fraction of the cost. While they're not FDA-approved in the same way brand-name versions are, they're made by licensed compounding pharmacies following strict quality standards.

From the Ozari Care Team

The honest answer to "which is better" is: the one you'll actually take consistently and that your body responds to well. We typically start patients on semaglutide because of its established track record, but if you plateau or experience tolerability issues, tirzepatide is an excellent next step. What matters most isn't which medication wins in a head-to-head trial—it's which one helps you reach your health goals with side effects you can manage.

Making Your Decision

Rather than asking "which is better," ask "which is better for me right now?" Consider your medical history, whether you've tried GLP-1 medications before, your budget, and honestly, your gut feeling after learning about both options.

The best medication is the one that helps you lose weight sustainably, improves your metabolic health, and fits into your life in a way that feels manageable for the long term. Both Zepbound and Wegovy can be powerful tools—they're just different tools, and you might need to try one to know if it's the right fit.

Talk with your healthcare provider about your specific situation. Bring up your concerns, your goals, and any previous experiences with weight loss medications. The decision should be collaborative, informed, and tailored to you.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026